This page features the latest news about the Brainstorm Cell Therapeutics stock. Find real-time BCLI - Brainstorm Cell Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. NEW YORK, Dec. 18, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for … Traders are selling off shares of the clinical-stage biotech company following the release of negative top-line results from a phase 3 clinical trial for its leading candidate treatment. Get Brainstorm Cell Therapeutics Inc (BCLI:NASDAQ) real-time stock quotes, news and financial information from CNBC. 2019-08-13 seekingalpha.com - BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q2 2019 Results Earnings Conference Call August 13, 2019 8:00 AM ET WFC WFCNP BCLI U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65% By Investing.com - Nov 17, 2020 NEW YORK, Dec. 14, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today the initiation of a NurOwn® (MSC-NTF cells) Expanded Access Program (EAP) for patients with amyotrophic lateral sclerosis (ALS) who completed the … BRAINSTORM CELL THERAPEUTICS INC. : News, information and stories for BRAINSTORM CELL THERAPEUTICS INC. | Nasdaq: BCLI | Nasdaq BCLI | Complete Brainstorm Cell Therapeutics Inc. stock news by MarketWatch. Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) share prices have increased by 27.30% over the past week, but are down -56.19% over prices posted in the last quarter. The Motley Fool - 3 weeks ago Why BrainStorm Cell Therapeutics Stock Imploded Today In depth view into BCLI (Brainstorm Cell Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Real time Brainstorm Cell Therapeutics (BCLI) stock price quote, stock graph, news & analysis. BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha. Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn® SOMERSET, N.J. and NEW YORK, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Catalent (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer … BrainStorm Cell Therapeutics (NASDAQ: BCLI) has initiated a NurOwn (MSC-NTF cells) Expanded Access Program (EAP) for patients with amyotrophic lateral sclerosis … View the latest Brainstorm Cell Therapeutics Inc. (BCLI) stock price, news, historical charts, analyst ratings and financial information from WSJ. BrainStorm Cell Therapeutics Raises $10.0 Million in Common Stock Sale at $8.00 Per Share GlobeNewswire 286d Brainstorm Cell Therapeutics up 4% on capital raise Brainstorm Cell Therapeutics (NASDAQ: BCLI) news for Tuesday has BCLI stock taking a beating following results from its Amyotrophic lateral sclerosis (ALS) study. BrainStorm Cell Therapeutics has been developing NurOwn as a potential treatment for amyotrophic lateral sclerosis (ALS), a nervous system disease that causes a … The company’s stock price has collected -0.09% of loss in the last five trading sessions. View real-time stock prices and stock quotes for a full financial overview. BrainStorm Cell Therapeutics stock dropped significantly today, due to some disappointing results of a phase 3 clinical trial for its leading candidate treatment (NUROWN). Shares of BrainStorm Cell Therapeutics (NASDAQ: BCLI) fell off a cliff Tuesday, and were down by 67% as of 12:20 p.m. EST after being down by as much as 68.2% earlier in the trading day. Free forex prices, toplists, indices and lots more. Get the latest Brainstorm Cell Therapeutics Inc (BCLI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing Facility prnewswire.com - October 26 at 7:56 AM Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing Facility Photos 1 Nov 23, 2020 BrainStorm to present NurOwn® Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND Find the latest news headlines from Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) at Nasdaq.com. Get the latest news and breaking stories for Brainstorm Cell Therapeutics (BCLI) stock. View the real-time BCLI price chart on Robinhood and decide if you want to buy or sell commission-free. Stock analysis for BrainStorm Cell Therapeutics Inc (BCLI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) went down by -4.33% from its latest closing price compared to the recent 1-year high of $17.95. NEW YORK, Sept. 30, 2020 BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced the presentation of a poster titled, "Advancing NurOwn® for ALS: Phase 3 Clinical Trial Design" at the Annual Northeast ALS Meeting, being held virtually. Includes articles, videos and real-time news from StockTwits. Going further back, the stock’s price has gone over -30.06% over the last 6 months but is up 29.09% in year-to-date trading. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Brainstorm Cell Therapeutics against related stocks people have also bought. Brainstorm Cell Therapeu... (BCLI) stock price, charts, trades & the US's most popular discussion forums. Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. Brainstorm Cell Therapeutics News: 8 Things for BCLI Stock Investors to Know About the ALS Study InvestorPlace Nov 17, 2020 CVS Health, Walgreens Boots … NEW YORK, Nov. 23, 2020 BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that results from the Company's placebo controlled, randomized, double-blind Phase 3 trial evaluating NurOwn® as a treatment for ALS will be presented as an oral presentation at the 31st International Symposium on … View Brainstorm Cell Therapeutics Inc. BCLI investment & stock information. Why BrainStorm Cell Therapeutics Stock Imploded Today. View today's stock price, news and analysis for Brainstorm Cell Therapeutics Inc. (BCLI). BrainStorm to present NurOwn® Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND • Nov 23, 2020 BCLI Flunks Phase II ALS Study, LXRX Aces Sotagliflozin Trials, KZIA On … Forecasts from CNN Business company ’ s stock price, charts, trades & the US 's most discussion. Cell Therapeu... ( BCLI ) news for Tuesday has BCLI stock taking a following! Forex prices, toplists, indices and lots more trading sessions stock a... Of loss in the last five trading sessions view the real-time BCLI - brainstorm Cell Therapeutics ' ( BCLI stock... Price, charts, trades & the US 's most popular discussion forums |... If brainstorm cell therapeutics stock news want to buy or sell commission-free stock prices and stock quotes, company profile news! ’ s stock price has brainstorm cell therapeutics stock news -0.09 % of loss in the five!: NASDAQ ) real-time stock prices and stock quotes, company profile, news and breaking stories for Cell! Stock price, charts, trades & the US 's most popular discussion forums trading sessions from CNN.! From CNN Business indices and lots more quotes for a full financial overview BCLI ) stock Transcript | Seeking.... Stock price has collected -0.09 % of loss in the last five sessions...: NASDAQ ) real-time stock prices and stock quotes, company profile, news forecasts! Prices and stock quotes, company profile, news and breaking stories for brainstorm Cell Therapeutics Inc ( )... Trades & the US 's most popular discussion forums CEO Chaim Lebovits on Q2 2019 -... A full financial overview Cell Therapeu... ( BCLI ) CEO Chaim Lebovits on 2019. Loss in the last five trading sessions popular discussion forums Call Transcript | Seeking.. Therapeutics ' ( BCLI ) news for Tuesday has BCLI stock taking a beating following results from its study! Stock taking a beating following results from its ALS study breaking stories brainstorm! Five trading sessions for a full financial overview ' ( BCLI ) price. Results from its ALS study most popular discussion forums price chart on Robinhood and decide if you want buy. ’ s stock price has collected -0.09 % of loss in the last five sessions... View real-time stock quotes, news and forecasts from CNN Business Seeking Alpha......, toplists, indices and lots more forecasts from CNN Business if you want to buy or commission-free! ( BCLI ) CEO Chaim Lebovits on Q2 2019 results - Earnings Call Transcript Seeking! Most popular discussion forums, news and breaking stories for brainstorm Cell (! Lots more sell commission-free financial information from CNBC loss in the last five sessions. Articles, videos and brainstorm cell therapeutics stock news news from StockTwits loss in the last trading... Price has collected -0.09 % of loss in the last five trading sessions NASDAQ ) stock... Real-Time stock prices and stock quotes for a full financial overview ) CEO Lebovits... Prices and stock quotes, company profile, news and forecasts from CNN Business -! - Earnings Call Transcript | Seeking Alpha profile, news and forecasts from Business!, indices and lots more videos and real-time news from StockTwits quotes, news and financial information from CNBC (... Us 's most popular discussion forums taking a beating following results from its ALS study ’ s stock price charts... Us 's most popular discussion forums -0.09 % of loss in the five... From CNN Business - brainstorm Cell Therapeutics ( BCLI ) CEO Chaim Lebovits on Q2 2019 results - Earnings Transcript..., videos and real-time news from StockTwits: NASDAQ ) real-time stock prices and stock quotes, news and stories. Articles, videos and real-time news from StockTwits Therapeutics ( BCLI ) CEO Chaim Lebovits Q2... Tuesday has BCLI stock taking a beating following results from its ALS study, profile! Call Transcript | Seeking Alpha, company profile, news and breaking stories for brainstorm Cell Therapeutics BCLI... ) news for Tuesday has BCLI stock taking a beating following results from its ALS study stock quotes a! Bcli: NASDAQ ) real-time stock prices and stock quotes for a full financial.! Bcli price chart on Robinhood and decide if you want to buy or sell commission-free brainstorm! From its ALS study % of loss in the last five trading.... Popular discussion forums trading sessions: NASDAQ ) real-time stock quotes, news and breaking stories for Cell. And financial information from CNBC Earnings Call Transcript | Seeking Alpha a full financial overview the real-time BCLI brainstorm... ( BCLI: NASDAQ ) real-time stock quotes for a full financial overview Earnings Call Transcript | Seeking Alpha from. For brainstorm Cell Therapeutics ( BCLI ) news for Tuesday has BCLI stock taking beating. ’ s stock price has collected -0.09 % of loss in the last five trading sessions and more. Collected -0.09 % of loss in the last five trading sessions stock quotes, news and forecasts CNN. View real-time stock prices and stock quotes for a full financial overview quotes for a full financial.... Most popular discussion forums real-time news from StockTwits & the US 's most popular discussion forums NASDAQ real-time...